Cargando…

Optimization of 4-Anilinoquinolines as Dengue Virus Inhibitors

Emerging viral infections, including those caused by dengue virus (DENV) and Venezuelan Equine Encephalitis virus (VEEV), pose a significant global health challenge. Here, we report the preparation and screening of a series of 4-anilinoquinoline libraries targeting DENV and VEEV. This effort generat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Pei-Tzu, Saul, Sirle, Einav, Shirit, Asquith, Christopher R. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659069/ https://www.ncbi.nlm.nih.gov/pubmed/34885921 http://dx.doi.org/10.3390/molecules26237338

Ejemplares similares

Anilinoquinoline based inhibitors of trypanosomatid proliferation
por: Ferrins, Lori, et al.
Publicado: (2018)

Synthesis and Anti-Tumor Activities of 4-Anilinoquinoline Derivatives
por: Liu, Dan, et al.
Publicado: (2015)

Synthesis of novel 6,7-dimethoxy-4-anilinoquinolines as potent c-Met inhibitors
por: Zhang, Qing-Wen, et al.
Publicado: (2018)

The cargo adapter protein CLINT1 is phosphorylated by the Numb-associated kinase BIKE and mediates dengue virus infection
por: Schor, Stanford, et al.
Publicado: (2022)

The transcriptional landscape of Venezuelan equine encephalitis virus (TC-83) infection
por: Yao, Zhiyuan, et al.
Publicado: (2021)

In-silico combinatorial design and pharmacophore modeling of potent antimalarial 4-anilinoquinolines utilizing QSAR and computed descriptors
por: Parihar, Neha, et al.
Publicado: (2015)

Molecular docking and QSAR studies for modeling the antimalarial activity of hybrids 4-anilinoquinoline-triazines derivatives with the wild-type and mutant receptor pf-DHFR
por: Hadni, Hanine, et al.
Publicado: (2019)

An 8-gene machine learning model improves clinical prediction of severe dengue progression
por: Liu, Yiran E., et al.
Publicado: (2022)

Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs
por: Schor, Stanford, et al.
Publicado: (2018)

Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies
por: Karim, Marwah, et al.
Publicado: (2022)

Synthesis and evaluation of 3-alkynyl-5-aryl-7-aza-indoles as broad-spectrum antiviral agents
por: Martinez-Gualda, Belén, et al.
Publicado: (2022)

Virus-inclusive single-cell RNA sequencing reveals the molecular signature of progression to severe dengue
por: Zanini, Fabio, et al.
Publicado: (2018)

Turning Up Your Nose for a Flaviviral Encephalitis Cure
por: Barouch-Bentov, Rina, et al.
Publicado: (2018)

Preparing for the next viral threat with broad-spectrum antivirals
por: Karim, Marwah, et al.
Publicado: (2023)

Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics
por: Durham, Natasha D, et al.
Publicado: (2019)

Versatile Trans-Replication Systems for Chikungunya Virus Allow Functional Analysis and Tagging of Every Replicase Protein
por: Utt, Age, et al.
Publicado: (2016)

Identification and Targeting of an Interaction between a Tyrosine Motif within Hepatitis C Virus Core Protein and AP2M1 Essential for Viral Assembly
por: Neveu, Gregory, et al.
Publicado: (2012)

Interactions between the Hepatitis C Virus Nonstructural 2 Protein and Host Adaptor Proteins 1 and 4 Orchestrate Virus Release
por: Xiao, Fei, et al.
Publicado: (2018)

A 20-Gene Set Predictive of Progression to Severe Dengue
por: Robinson, Makeda, et al.
Publicado: (2019)

Glycyrrhizic acid derivatives as Dengue virus inhibitors
por: Baltina, Lidia A., et al.
Publicado: (2019)

Viral journeys on the intracellular highways
por: Robinson, Makeda, et al.
Publicado: (2018)

2565. A Novel Prognostic Gene Set for the Prediction of Severe Dengue
por: Robinson, Makeda L, et al.
Publicado: (2018)

Synthetic 1,4-Pyran Naphthoquinones Are Potent Inhibitors of Dengue Virus Replication
por: da Costa, Emmerson C. B., et al.
Publicado: (2013)

Small-Molecule Inhibitors of Dengue-Virus Entry
por: Schmidt, Aaron G., et al.
Publicado: (2012)

Single-cell transcriptional dynamics of flavivirus infection
por: Zanini, Fabio, et al.
Publicado: (2018)

Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects
por: Saul, Sirle, et al.
Publicado: (2023)

Peptide inhibitors of dengue virus and West Nile virus infectivity
por: Hrobowski, Yancey M, et al.
Publicado: (2005)

Crabohydrate-Related Inhibitors of Dengue Virus Entry
por: Hidari, Kazuya I.P.J., et al.
Publicado: (2013)

Release of Dengue Virus Genome Induced by a Peptide Inhibitor
por: Lok, Shee-Mei, et al.
Publicado: (2012)

Progress in the Identification of Dengue Virus Entry/Fusion Inhibitors
por: De La Guardia, Carolina, et al.
Publicado: (2014)

Correction: Small-Molecule Inhibitors of Dengue-Virus Entry
por: Schmidt, Aaron G., et al.
Publicado: (2019)

Dengue Virus
por: Ross, Ted M.
Publicado: (2010)

MARCH8 Ubiquitinates the Hepatitis C Virus Nonstructural 2 Protein and Mediates Viral Envelopment
por: Kumar, Sathish, et al.
Publicado: (2019)

Structural Optimization and De Novo Design of Dengue Virus Entry Inhibitory Peptides
por: Costin, Joshua M., et al.
Publicado: (2010)

Dengue Virus Serotype 4 Is Responsible for the Outbreak of Dengue in East Java City of Jember, Indonesia
por: Aryati, Aryati, et al.
Publicado: (2020)

Detection of dengue virus 4 from central India
por: Barde, P.V., et al.
Publicado: (2012)

Occurrence of 4 Dengue Virus Serotypes and Chikungunya Virus in Kilombero Valley, Tanzania, During the Dengue Outbreak in 2018
por: Chipwaza, Beatrice, et al.
Publicado: (2020)

Dengue Virus Type 4, Manaus, Brazil
por: Pinto de Figueiredo, Regina Maria, et al.
Publicado: (2008)

Optimal bang-bang control for variable-order dengue virus; numerical studies()
por: Sweilam, N.H., et al.
Publicado: (2021)

Dengue Virus
por: Murugesan, Amudhan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0e8i1m85ta6q7kdls4aq40ui8j